1. | samkylie | |
2. | cyberspacer | |
3. | alein99 | |
4. | SebastianXL | |
5. | tgcakeylvam |
1. | samkylie | |
2. | cyberspacer | |
3. | alein99 | |
4. | SebastianXL | |
5. | tgcakeylvam |
1. | cyberspacer 01/02/2018 Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer |
2. | alein99 02/26/2018 This looks interesting here. |
3. | SebastianXL 09/30/2017 TETRAPHASE PHARMACEUTICALS TO PRESENT DATA AT IDWEEK 2017 WATERTOWN, Mass., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical compa |
4. | cyberspacer 09/30/2017 This I believe is a decent buyout hopeful. |
5. | tgcakeylvam 02/26/2018 I have no doubt we close the $5 gap soon {Image} |
6. | alein99 09/30/2017 Presenting data in Oct |
7. | bcavage 02/26/2018 Why didn't I buy back 2 months ago? |
8. | samkylie 02/14/2018 H.C. Wainwright Slashes Price Target for Tetraphase Pharmaceuticals Inc (TTPH); Here's Why |
9. | SebastianXL 02/20/2018 The more you know. - |
10. | samkylie 02/13/2018 Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline in Complicated Urinary Tract Infections (cUTI) |